Company · CAMP
CAMP4 Therapeutics Corporation
Name as listed on its exchange; filed with the SEC as Camp4 Therapeutics Corp.
Nasdaq's symbol directory lists CAMP on Nasdaq as “CAMP4 Therapeutics Corporation - Common Stock”.
In the 12 months to Nov 8, 2026: insiders bought on 5 occasions ($99K); insiders sold on 6 occasions ($2.5M); 6 filings by holders of 5% or more; 2 company reports (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Andrew J. Schwab sold $2.5M
- Kelly Gold, Chief Financial Officer bought $50K
- Young Richard A bought $27K
- Mandel-Brehm Josh, Chief Executive Officer bought $11K
- Maricich Yuri, Chief Medical Officer bought $11K
- Tardiff Daniel, Chief Scientific Officer sold $8K
Every trade (11)
- BUYKelly Gold, Chief Financial Officer bought $40K
- SELLAndrew J. Schwab sold $1.6M
- SELLAndrew J. Schwab sold $45
- SELLAndrew J. Schwab sold $144K
- SELLAndrew J. Schwab sold $521K
- SELLAndrew J. Schwab sold $215K
- SELLTardiff Daniel, Chief Scientific Officer sold $8K
- BUYYoung Richard A bought $27K
- BUYKelly Gold, Chief Financial Officer bought $11K
- BUYMandel-Brehm Josh, Chief Executive Officer bought $11K
- BUYMaricich Yuri, Chief Medical Officer bought $11K
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- FMR LLC 7.8%
- 5AM Ventures VI, L.P. 9.9%
- Polaris Management Co. VII, L.L.C. 4.8%
- BALYASNY ASSET MANAGEMENT L.P. 4.99%
- Trails Edge Capital Partners, LP 6%
- 5AM Ventures VI, L.P. 4.2%
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Financial statements and exhibits Nov 5, 2026
- Regulation FD disclosure; Other events Sep 28, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.